Leupin Nicolas - Mar 4, 2025 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role: Chief Medical Officer
Signature: Steven Robbins, as attorney in fact for Leupin, Nicolas
Stock symbol: NVCR
Transactions as of: Mar 4, 2025
Transactions value $: $2,482,462
Form type: 4
Date filed: 3/6/2025, 04:42 PM
Previous filing: Mar 3, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCR	Ordinary Shares	Award	$1M	+55K	+109.66%	$18.19	105K	Mar 4, 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NVCR	Stock Options (Right to buy)	Award	$1.48M	+81.5K		$18.19	81.5K	Mar 4, 2025	Ordinary Shares	81.5K	$18.19	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted share units that are scheduled to vest in equal installments on March 4, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates.
F2	Options to buy 81,499 ordinary shares will vest in equal installments on each of March 4, 2026, 2027, 2028 and 2029, subject to the reporting person's continued employment through such dates.